Clinical trial
Vaccine Therapy, Paclitaxel, and Carboplatin in Treating Patients Who Are…
NCT00373217 · Craig L Slingluff, Jr, Other · Terminated
Key facts
| NCT number | NCT00373217 |
|---|---|
| Title | Vaccine Therapy, Paclitaxel, and Carboplatin in Treating Patients Who Are Undergoing Surgery for Stage III or Stage IV Ovarian Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer |
| Official title | Evaluation of the Immunogenicity of Vaccination With Synthetic Peptides in Adjuvant in Patients With Advanced Ovarian, Primary Peritoneal, or Fallopian Tube Cancer |
| Lead sponsor | Craig L Slingluff, Jr, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer |
| Intervention type | Biological, Drug, Procedure |
| Interventions | MAGE-A1, Her-2/neu, FBP peptides ovarian cancer vaccine, tetanus toxoid helper peptide, carboplatin, paclitaxel, conventional surgery |
| Enrollment | 6 |
| Start date | Apr 13, 2006 |
| Primary completion | Feb 7, 2008 |
| Completion | Feb 7, 2008 |
| First posted | Sep 7, 2006 |
| Last update posted | Sep 21, 2022 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: